Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,489,509
+$124,485 QoQ
Shares Held
17,841
-11.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,383
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $33,905,175 across 13 Drug Manufacturers - General names. ABBV ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,521 | $9,020,913 | |
| 2 | JNJ |
Johnson & Johnson
|
21,897 | $5,561,181 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
17,841 | $4,489,509 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,088 | $2,581,308 | |
| 5 | AMGN |
Amgen Inc
|
6,469 | $2,342,554 | |
| 6 | AZN |
Astrazeneca PLC
|
11,190 | $2,121,847 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,328 | $1,689,879 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,413 | $1,568,258 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,489,509 | 17,841 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,365,024 | 20,070 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,584,651 | 20,065 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,306,665 | 22,919 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,094,591 | 22,059 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,621,801 | 22,059 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,808,999 | 21,435 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,232,983 | 21,435 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,676,531 | 21,435 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,067,931 | 22,339 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,343,322 | 21,574 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,118,931 | 20,924 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,713,731 | 20,142 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,940,217 | 18,449 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,951,483 | 18,263 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,138,502 | 15,934 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,189,403 | 20,824 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,135,855 | 19,344 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,966,143 | 14,521 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $1,566,380 | 14,521 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,474,795 | 13,093 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,416,924 | 13,093 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,402,914 | 13,093 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,000,277 | 11,420 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,121,215 | 11,420 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $911,537 | 11,964 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||